Literature DB >> 10334432

Acute and long-term cost implications of coronary stenting.

E D Peterson1, P A Cowper, E R DeLong, J P Zidar, R S Stack, D B Mark.   

Abstract

OBJECTIVES: We compared the acute and one year medical costs and outcomes of coronary stenting with those for balloon angioplasty (percutaneous transluminal coronary angioplasty) in contemporary clinical practice.
BACKGROUND: While coronary stent implantation reduces the need for repeat revascularization, it has been associated with significantly higher acute costs compared with coronary angioplasty.
METHODS: We studied patients treated at Duke University between September 1995 and June 1996 who received either coronary stent (n = 384) or coronary angioplasty (n = 159) and met eligibility criteria. Detailed cost data were collected initially and up to one year following the procedure. Our primary analyses compared six and 12 month cumulative costs for coronary angioplasty- and stent-treated cohorts. We also compared treatment costs after excluding nontarget vessel interventions; after limiting analysis to those without prior revascularization; and after risk-adjusting cumulative cost estimates.
RESULTS: Baseline clinical characteristics were generally similar between the two treatment groups. The mean in-hospital cost for stent patients was $3,268 higher than for those receiving coronary angioplasty ($14,802 vs. $11,534, p < 0.001). However, stent patients were less likely to be rehospitalized (22% vs. 34%, p = 0.002) or to undergo repeat revascularization (9% vs. 26%, p = 0.001) than coronary angioplasty patients within six months of the procedure. As such, mean cumulative costs at 6 months ($19,598 vs. $19,820, p = 0.18) and one year ($22,140 vs. $22,571, p = 0.26) were similar for the two treatments. Adjusting for baseline predictors of cost and selectively examining target vessel revascularization, or those without prior coronary intervention yielded similar conclusions.
CONCLUSIONS: In contemporary practice, coronary stenting provides equivalent or better one-year patient outcomes without increasing cumulative health care costs.

Entities:  

Mesh:

Year:  1999        PMID: 10334432     DOI: 10.1016/s0735-1097(99)00051-0

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  4 in total

1.  Long term outcome and cost-effectiveness of stenting versus balloon angioplasty for acute myocardial infarction.

Authors:  H Suryapranata; J P Ottervanger; E Nibbering; A W van 't Hof; J C Hoorntje; M J de Boer; M J Al; F Zijlstra
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

2.  Cost-effectiveness modelling of percutaneous coronary interventions in stable coronary artery disease.

Authors:  Ariel Beresniak; Thibaut Caruba; Brigitte Sabatier; Yves Juillière; Olivier Dubourg; Nicolas Danchin
Journal:  World J Cardiol       Date:  2015-10-26

3.  The use of patient mix-adjusted control charts to compare in-hospital costs of care.

Authors:  E L Eisenstein; C F Bethea
Journal:  Health Care Manag Sci       Date:  1999-12

4.  Titanium-nitride-oxIde-coated stents multicenter registry in diaBEtic patienTs: the TIBET registry.

Authors:  Mariano Valdés Chavarri; Mariano Valdés Chavarri; Armando Bethencourt; Eduardo Pinar; Alfredo Gomez; Javier Fernández Portales; Francisco Pomar; Isabel Calvo; Jose Ramón López-Minguez; Jose Ramón López Minguez; Raúl Valdesuso; José Moreu; Antonio Martínez; Wail Nammas
Journal:  Heart Vessels       Date:  2011-03-30       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.